WG Biotech ApS: Financial statements 2023
CVR: 36940131
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
WG Biotech ApS (CVR 36940131) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 48,499,000 and a net result of DKK 48,874,000 compared with DKK -300,233,000 the year before. Equity in the 2023 report amounted to DKK 260,908,000. The solvency ratio was 95.5%.
- Gross Profit
- DKK 48,499,000
- Profit/Loss
- DKK 48,874,000
- Equity
- DKK 260,908,000
- Total Assets
- DKK 273,220,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 48.5 mio. | 48.9 mio. | 260.9 mio. | - |
| 2022 | - | -302.3 mio. | -300.2 mio. | 202.9 mio. | - |
| 2021 | - | -915.8 mio. | -913.9 mio. | 503.1 mio. | - |
| 2020 | - | - | 502.6 mio. | 1.6 mia. | - |
| 2019 | - | - | 389.5 mio. | 1.1 mia. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
WG Biotech ApS has published its annual report for 2022. Gross profit came to DKK -302,272,000, and the net result was DKK -300,233,000.
About WG Biotech ApS
WG Biotech ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2015. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Johan Ernst Wedell-Wedellsborg. The company is owned by WECO A/S and WG Biotech ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,963,000 and a net result of DKK 2,166,000 compared with DKK 48,534,000 the year before. Equity in the 2025 report amounted to DKK 311,608,000.